Haili Biotech announced that the company officially closed the production line of the Shanghai factory from the same day, and the relevant production capacity will be mainly transferred to Shandong Haili, a wholly-owned subsidiary. Due to the relocation involved, according to the provisions of the state, it is necessary to obtain re-approval from the Ministry of Agriculture and Rural Affairs and other relevant competent departments before production and sales, which generally takes 6-9 months and is uncertain.
The chairman of the company is Zhang Yue. Ms. Zhang Yue: Born in 1989, Chinese nationality, French permanent residency, master's degree, graduated from the Paris Ecole Supérieure des Sciences, Technology and Economics and Business (ISTECParis), Bachelor's degree in Economics and Management, bachelor's degree, master's degree, postgraduate degree. He is currently the chairman of the board of directors of the company, and also serves as the director of Shanghai Jiemen Biotechnology Co., Ltd., the director of Shandong Haili Biological Products Co., Ltd., the director of Hangzhou Shuchen Biotechnology Co., Ltd., and the partner of Suzhou Tonghe Venture Capital Partnership (Limited Partnership), the partner of Suzhou Tonghe Phase II Venture Capital Partnership (Limited Partnership), and has rich experience in investment and financing and enterprise management.
The above content is compiled by Securities Star based on public information, if you have any questions, please contact us.